Neutrophil/granulocyte transfusions collected from G-CSF plus dexamethasone-stimulated donors

被引:10
|
作者
Strauss, Ronald G. [1 ,2 ]
机构
[1] Univ Iowa, Coll Med, Iowa City, IA USA
[2] LifeSource ITxM, Rosemont, IL USA
关键词
G-CSF plus dexamethasone donor stimulation; neutropenic infections; neutrophil; granulocyte transfusions; optimal neutrophil; granulocyte leukapheresis; therapeutic neutrophil; THERAPEUTIC GRANULOCYTE TRANSFUSIONS; SEPTICEMIA; LEUKEMIA; EFFICACY; TRIAL;
D O I
10.1097/MOH.0000000000000189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewThe purpose of this review is to report a recently completed multicenter randomized controlled trial of neutrophil/granulocyte transfusions collected from G-CSF + dexamethasone donors to treat neutropenic infections in oncology and transplant patients, within the context of other historic and current clinical trials.The multicenter trial (RING Study) was funded by the NHLBI transfusion medicine/hemostasis clinical trials network.Recent findingsThere was no significant benefit of therapeutic neutrophil/granulocyte transfusions versus antibiotics per intention to treat analysis, but 32% of patients received substandard neutrophil doses. Separate analysis suggested patients given a higher neutrophil doses had better outcomes.SummaryEfficacy of high-dose' therapeutic neutrophil/granulocyte transfusions remains unproven, but promising.
引用
收藏
页码:565 / 567
页数:3
相关论文
共 50 条
  • [21] G-CSF mobilized granulocyte transfusions in 20 children with neutropenic sepsis.
    Grigull, L
    Pulver, N
    Welte, K
    Schrappe, M
    Lauten, M
    Sykora, KW
    Sander, A
    Schrauder, A
    Heuft, HG
    BLOOD, 2002, 100 (11) : 138B - 138B
  • [22] G-CSF plus dexamethasone administration produces greater granulocyte concentrate yields while causing no more donor toxicity than G-CSF alone.
    Stroncek, DF
    Yau, YY
    Leitman, SF
    BLOOD, 2000, 96 (11) : 62A - 63A
  • [23] G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis
    Grigull, Lorenz
    Pulver, Nicole
    Goudeva, Lilia
    Sykora, Karl-Walter
    Linderkamp, Christin
    Beilken, Andreas
    Seidemann, Kathrin
    Schmid, Hansjoerg
    Welte, Karl
    Heuft, Hans-Gert
    SUPPORTIVE CARE IN CANCER, 2006, 14 (09) : 910 - 916
  • [24] G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis
    Lorenz Grigull
    Nicole Pulver
    Lilia Goudeva
    Karl-Walter Sykora
    Christin Linderkamp
    Andreas Beilken
    Kathrin Seidemann
    Hansjörg Schmid
    Karl Welte
    Hans-Gert Heuft
    Supportive Care in Cancer, 2006, 14 : 910 - 916
  • [25] Granulocyte transfusions in the G-CSF era. Where do we stand?
    Robinson, SP
    Marks, DI
    BONE MARROW TRANSPLANTATION, 2004, 34 (10) : 839 - 846
  • [26] Effect of single dose G-CSF on platelet function in granulocyte donors
    Bayraktar, N.
    Avci, Z.
    Malbora, B.
    Haberal, A.
    Goksel, K.
    Ozbek, N.
    Turan, M.
    FEBS JOURNAL, 2011, 278 : 434 - 435
  • [27] Blood counts and serum chemistry determinations in granulocyte donors given granulocyte colony-stimulating factor (G-CSF) and dexamethasone (DEX).
    Stroncek, DF
    Yau, YY
    Carr, JM
    Leitman, SF
    BLOOD, 1998, 92 (10) : 138B - 138B
  • [28] Phenotypic changes in neutrophil granulocytes from healthy donors after G-CSF administration
    Zarco, MA
    Ribera, JM
    Urbano-Ispizua, A
    Filella, X
    Arriols, R
    Martínez, C
    Feliu, E
    Montserrat, E
    HAEMATOLOGICA, 1999, 84 (10) : 874 - 878
  • [29] Granulocyte collection from donors primed with G-CSF and corticosteroids using Dideco Excel Equipment
    Lemos, MM
    De Santis, GC
    Prado, BP
    Covas, DT
    Zago, MA
    TRANSFUSION, 2001, 41 (09) : 122S - 123S
  • [30] Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases
    Cesaro, S
    Chinello, P
    De Silvestro, G
    Marson, P
    Picco, G
    Varotto, S
    Pittalis, S
    Zanesco, L
    SUPPORTIVE CARE IN CANCER, 2003, 11 (02) : 101 - 106